ilmscore | Prediction Details
By Stock Market Live | July 30, 2024 | Pending
Interpreted Prediction
Pfizer (PFE) is on track to achieve at least $4 billion in net savings from its cost realignment program by the end of 2024.

Prediction Details

Ticker

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.